139 related articles for article (PubMed ID: 10521053)
1. Early onset of breast carcinoma in African American women with poor prognostic factors.
Aziz H; Hussain F; Sohn C; Mediavillo R; Saitta A; Hussain A; Brandys M; Homel P; Rotman M
Am J Clin Oncol; 1999 Oct; 22(5):436-40. PubMed ID: 10521053
[TBL] [Abstract][Full Text] [Related]
2. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.
Lund MJ; Trivers KF; Porter PL; Coates RJ; Leyland-Jones B; Brawley OW; Flagg EW; O'Regan RM; Gabram SG; Eley JW
Breast Cancer Res Treat; 2009 Jan; 113(2):357-70. PubMed ID: 18324472
[TBL] [Abstract][Full Text] [Related]
3. African-American/White differences in breast carcinoma: p53 alterations and other tumor characteristics.
Jones BA; Kasl SV; Howe CL; Lachman M; Dubrow R; Curnen MM; Soler-Vila H; Beeghly A; Duan F; Owens P
Cancer; 2004 Sep; 101(6):1293-301. PubMed ID: 15368321
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes and clinicopathologic differences of African-American versus white patients treated with breast conservation therapy for early-stage breast cancer.
Moran MS; Yang Q; Harris LN; Jones B; Tuck DP; Haffty BG
Cancer; 2008 Nov; 113(9):2565-74. PubMed ID: 18816610
[TBL] [Abstract][Full Text] [Related]
5. Poor survival of black patients in carcinoma of the endometrium.
Aziz H; Rotman M; Hussain F; Smith G; Chan E; Choi K; Sohn C; Halpern J; Schwartz D; Aral I
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):293-301. PubMed ID: 8407403
[TBL] [Abstract][Full Text] [Related]
6. Racial differences in breast carcinoma survival.
Joslyn SA; West MM
Cancer; 2000 Jan; 88(1):114-23. PubMed ID: 10618613
[TBL] [Abstract][Full Text] [Related]
7. Prognostic indices in breast cancer are related to race.
Kotwall CA; Brinker CC; Covington DL; Hall TL; Maxwell JG
Am Surg; 2003 May; 69(5):372-6. PubMed ID: 12769206
[TBL] [Abstract][Full Text] [Related]
8. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.
Elledge RM; Clark GM; Chamness GC; Osborne CK
J Natl Cancer Inst; 1994 May; 86(9):705-12. PubMed ID: 7908990
[TBL] [Abstract][Full Text] [Related]
9. Histologic grade, stage, and survival in breast carcinoma: comparison of African American and Caucasian women.
Henson DE; Chu KC; Levine PH
Cancer; 2003 Sep; 98(5):908-17. PubMed ID: 12942556
[TBL] [Abstract][Full Text] [Related]
10. Survival differences between black and white women with breast cancer.
Elias EG; Suter CM; Brown SD; Buda BS; Vachon DA
J Surg Oncol; 1994 Jan; 55(1):37-41. PubMed ID: 8289451
[TBL] [Abstract][Full Text] [Related]
11. Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease.
Gnerlich JL; Deshpande AD; Jeffe DB; Sweet A; White N; Margenthaler JA
J Am Coll Surg; 2009 Mar; 208(3):341-7. PubMed ID: 19317994
[TBL] [Abstract][Full Text] [Related]
12. Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma.
Porter PL; Lund MJ; Lin MG; Yuan X; Liff JM; Flagg EW; Coates RJ; Eley JW
Cancer; 2004 Jun; 100(12):2533-42. PubMed ID: 15197793
[TBL] [Abstract][Full Text] [Related]
13. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry.
Bauer KR; Brown M; Cress RD; Parise CA; Caggiano V
Cancer; 2007 May; 109(9):1721-8. PubMed ID: 17387718
[TBL] [Abstract][Full Text] [Related]
14. There is no difference in survival between African-American and white women with breast cancer.
English WP; Cleveland KE; Barber WH
Am Surg; 2002 Jun; 68(6):594-7. PubMed ID: 12079146
[TBL] [Abstract][Full Text] [Related]
15. p53 as a marker of prognosis in African-American women with breast cancer.
Dookeran KA; Dignam JJ; Ferrer K; Sekosan M; McCaskill-Stevens W; Gehlert S
Ann Surg Oncol; 2010 May; 17(5):1398-405. PubMed ID: 20049641
[TBL] [Abstract][Full Text] [Related]
16. The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999-2004.
Brown M; Tsodikov A; Bauer KR; Parise CA; Caggiano V
Cancer; 2008 Feb; 112(4):737-47. PubMed ID: 18189290
[TBL] [Abstract][Full Text] [Related]
17. Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial.
Sparano JA; Wang M; Zhao F; Stearns V; Martino S; Ligibel JA; Perez EA; Saphner T; Wolff AC; Sledge GW; Wood WC; Davidson NE
J Natl Cancer Inst; 2012 Mar; 104(5):406-14. PubMed ID: 22250182
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of clinicopathological characteristics and prognosis for triple negative breast cancer: a report of 108 cases].
Guan Y; Xu BH
Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):196-9. PubMed ID: 18756935
[TBL] [Abstract][Full Text] [Related]
19. Breast carcinoma survival analysis for African American and white women in an equal-access health care system.
Wojcik BE; Spinks MK; Optenberg SA
Cancer; 1998 Apr; 82(7):1310-8. PubMed ID: 9529023
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of triple-negative tumors in an urban cancer center.
Lund MJ; Butler EN; Bumpers HL; Okoli J; Rizzo M; Hatchett N; Green VL; Brawley OW; Oprea-Ilies GM; Gabram SG
Cancer; 2008 Aug; 113(3):608-15. PubMed ID: 18484596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
